Back to mobile site

UPDATE: Morgan Stanley Downgrades Amneal Pharmaceuticals (AMRX) to Equalweight

December 14, 2018 6:55 AM EST Send to a Friend
(Updated - December 14, 2018 8:28 AM EST)

(updated to add analyst comment)Morgan Stanley analyst David Risinger downgraded ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login